Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC) [Phase 2]
Phase 2 trial of GTx-024 in androgen receptor–positive triple negative breast cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating tivozanib in combination with paclitaxel for locally recurrent or metastatic triple negative breast cancer was term…
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBC [Phase 2]
Phase 2 trial evaluating SHR-1210 (anti-PD-1) with apatinib in advanced triple-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: Eribulin Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC) [Phase 2]
Phase 2 trial comparing eribulin plus cisplatin versus gemcitabine plus cisplatin in triple-negative breast cancer is reported as ongoing wi…
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC) [Phase 1, Phase 2]
Phase 1/2 trial evaluating eribulin mesylate with pembrolizumab in metastatic triple-negative breast cancer completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Maintenance Treatment With Eribulin Mesylate Versus Observation in Triple Negative Breast Cancer Patients [Phase 2]
Phase 2 trial comparing maintenance eribulin mesylate to observation in triple negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer [Phase 1, Phase 2]
This trial update reports Phase 1/2 results for the combination of cediranib and olaparib in recurrent ovarian, fallopian tube, or primary p…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: 2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed plus sorafenib for recurrent or metastatic triple negative breast cancer has been terminated with result…
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating pembrolizumab with capecitabine for locally advanced or metastatic triple-negative breast cancer or hormone-refract…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating safety and efficacy of durvalumab plus paclitaxel in metastatic triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-06-01Clinical Trial Update: Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating the clinical value of traditional Chinese medicine as adjuvant therapy for triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC) [Phase 3]
A Phase 3 clinical trial comparing TQB2450 plus anlotinib hydrochloride versus paclitaxel for injection in triple-negative breast cancer is …
-
CLINICAL_TRIALS trial_result · 2020-05-19Clinical Trial Update: Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN) [Phase 3]
Phase 3 trial update for adjuvant platinum and taxane in triple-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119) [Phase 3]
Phase 3 trial comparing single-agent pembrolizumab to single-agent chemotherapy in metastatic triple-negative breast cancer has completed wi…
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) [Phase 3]
A Phase 3 trial comparing paclitaxel plus carboplatin versus anthracyclines followed by docetaxel as adjuvant chemotherapy for triple negati…
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of TAK-659 in combination with nivolumab in advanced solid tumors was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency [Phase 2]
Phase 2 trial comparing paclitaxel and olaparib versus paclitaxel/carboplatin followed by epirubicin/cyclophosphamide as neoadjuvant therapy…
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC) [Phase 3]
Phase 3 clinical trial evaluating HLX10 with chemotherapy as neoadjuvant therapy and HLX10 with placebo as adjuvant therapy versus control i…
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers [Phase 1, Phase 2]
A phase 1/2 trial evaluating AZD2014 in combination with selumetinib in advanced cancers, including triple-negative breast cancer and squamo…
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating niraparib in combination with pembrolizumab in triple-negative breast cancer and ovarian cancer has been complete…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer [Phase 2]
Phase II study assessing neoadjuvant weekly paclitaxel and carboplatin followed by dose-dense epirubicin and cyclophosphamide in stage II-II…
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating autologous hematopoietic stem cell transplantation as adjuvant treatment for patients with residual tumor …
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer [Phase 1, Phase 2]
A combined regimen including SHR-1210 with albumin-bound paclitaxel and epirubicin is being investigated as neoadjuvant therapy for triple-n…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating MK-3475 (pembrolizumab) in combination with INCB024360 in various selected cancers; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer [Phase 2]
This update reports a Phase 2 neoadjuvant study of carboplatin plus docetaxel in triple-negative breast cancer.